Literature DB >> 22257558

Global trend of survival and damage of systemic lupus erythematosus: meta-analysis and meta-regression of observational studies from the 1950s to 2000s.

Anselm Mak1, Mike W-L Cheung, Hui Jin Chiew, Yang Liu, Roger Chun-man Ho.   

Abstract

OBJECTIVE: To assess systemically with meta-analysis the trend of survival and its determinants, which are hindering further improvement of survival of patients with systemic lupus erythematosus (SLE) over the past 5 decades.
METHODS: Retrospective, cross-sectional, and prospective observational studies addressing survival and damage in SLE patients published between 1 January 1950 and 31 July 2010 were identified in electronic databases. Using the random-effects model, effect size was calculated based on the logit of the overall 5- and 10-year survival rates. The pooled logit and its robust 95% confidence interval were transformed back into the 5- and 10-year survival rates, after adjusting for potential dependence on the data. Potential factors predicting the pooled survival rates were explored by meta-regression.
RESULTS: Seventy-seven studies involving 18,998 SLE patients were analyzed. Between the 1950s and the 2000s, their overall survival significantly increased, from 74.8% to 94.8% and 63.2% to 91.4% for the overall 5-year and 10-year survival, respectively (P < 0.001). The survival improvement, however, appeared to slow down between 1980 and 1990. Meta-regression revealed that neuropsychiatric and renal damage negatively affected the overall 5-year survival, whereas neuropsychiatric damage remained so for the 10-year survival for the past 50 years. Furthermore, the prevalence of neuropsychiatric damage has been significantly increasing over the past 5 decades.
CONCLUSIONS: For the past 50 years, damage involving the renal and neuropsychiatric systems has been negatively affecting survival of SLE patients. Early detection and aggressive management of renal and neuropsychiatric involvement may potentially improve further the survival of lupus patients.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22257558     DOI: 10.1016/j.semarthrit.2011.11.002

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  56 in total

1.  Longitudinal Study of Fatigue, Stress, and Depression: Role of Reduction in Stress Toward Improvement in Fatigue.

Authors:  Desiree R Azizoddin; Meenakshi Jolly; Shilpa Arora; Edward Yelin; Patricia Katz
Journal:  Arthritis Care Res (Hoboken)       Date:  2020-10       Impact factor: 4.794

2.  Homocysteine levels are independently associated with damage accrual in systemic lupus erythematosus patients from a Latin-American cohort.

Authors:  Paola A Zeña-Huancas; Haydee Iparraguirre-López; Rocío V Gamboa-Cárdenas; Cristina Reátegui-Sokolova; Francisco Zevallos-Miranda; Mariela Medina-Chinchon; Victor R Pimentel-Quiroz; Claudia Elera-Fitzcarrald; Omar Sarmiento-Velasquez; Jorge M Cucho-Venegas; José L Alfaro-Lozano; Zoila J Rodríguez-Bellido; César A Pastor-Asurza; Risto A Perich-Campos; Graciela S Alarcón; Manuel F Ugarte-Gil
Journal:  Clin Rheumatol       Date:  2018-12-12       Impact factor: 2.980

Review 3.  The need to define treatment goals for systemic lupus erythematosus.

Authors:  Kate Franklyn; Alberta Hoi; Mandana Nikpour; Eric F Morand
Journal:  Nat Rev Rheumatol       Date:  2014-07-22       Impact factor: 20.543

4.  Burden of Serious Infections in Adults With Systemic Lupus Erythematosus: A National Population-Based Study, 1996-2011.

Authors:  Maria G Tektonidou; Zhong Wang; Abhijit Dasgupta; Michael M Ward
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-08       Impact factor: 4.794

Review 5.  Glucocorticoids pharmacology and their application in the treatment of childhood-onset systemic lupus erythematosus.

Authors:  Jianghong Deng; Nathalie E Chalhoub; Catherine M Sherwin; Caifeng Li; Hermine I Brunner
Journal:  Semin Arthritis Rheum       Date:  2019-03-16       Impact factor: 5.532

6.  E3 ligase FBXW7 aggravates TMPD-induced systemic lupus erythematosus by promoting cell apoptosis.

Authors:  Zhenlu Chong; Chunjing Bao; Jia He; Tianxiao Chen; Lijia Zhong; Gaopeng Li; Huanle Li; Lutong Fang; Yinjing Song; Guoxiang Fu; Xuyan Yang; Lihua Lai; Yang Liu; Qingqing Wang
Journal:  Cell Mol Immunol       Date:  2018-10-01       Impact factor: 11.530

Review 7.  Global trends, potential mechanisms and early detection of organ damage in SLE.

Authors:  Anselm Mak; David A Isenberg; Chak-Sing Lau
Journal:  Nat Rev Rheumatol       Date:  2012-12-11       Impact factor: 20.543

Review 8.  Systemic lupus erythematosus and the economic perspective: a systematic literature review and points to consider.

Authors:  Giuseppe Turchetti; Jinoos Yazdany; Ilaria Palla; Edward Yelin; Marta Mosca
Journal:  Clin Exp Rheumatol       Date:  2012-10-16       Impact factor: 4.473

9.  Creatinine clearance rate predicts prognosis of patients with systemic lupus erythematosus: a large retrospective cohort study.

Authors:  Jiahuan Ge; Ziyi Jin; Xuebing Feng; Wenyou Pan; Lin Liu; Min Wu; Huaixia Hu; Xiang Ding; Hua Wei; Yaohong Zou; Xian Qian; Meimei Wang; Jian Wu; Juan Tao; Jun Tan; Zhanyun Da; Miaojia Zhang; Jing Li; Lingyun Sun
Journal:  Clin Rheumatol       Date:  2020-11-05       Impact factor: 2.980

10.  CTLA-4 polymorphisms and systemic lupus erythematosus (SLE): a meta-analysis.

Authors:  Jin-Xia Zhai; Li-Wei Zou; Zhao-Xiang Zhang; Wen-Jing Fan; Han-Yong Wang; Ting Liu; Zheng Ren; Rui-Xue Dai; Dongqing Ye
Journal:  Mol Biol Rep       Date:  2013-08-07       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.